C. Aros

1.3k total citations
18 papers, 954 citations indexed

About

C. Aros is a scholar working on Nephrology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C. Aros has authored 18 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 4 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C. Aros's work include Chronic Kidney Disease and Diabetes (7 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). C. Aros is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Renal Diseases and Glomerulopathies (3 papers). C. Aros collaborates with scholars based in Chile, Italy and Brazil. C. Aros's co-authors include Sergio Mezzano, Leopoldo Ardiles, M. Eugenia Burgos, Alejandra Droguett, Claudio Flores, Marta Ruiz‐Ortega, Jesús Egido, J. Egido, H. Schneider and I Caorsi and has published in prestigious journals such as Diabetes Care, Kidney International and Frontiers in Immunology.

In The Last Decade

C. Aros

17 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Aros Chile 10 405 260 242 208 120 18 954
Claudio Flores Chile 13 385 1.0× 365 1.4× 155 0.6× 183 0.9× 149 1.2× 16 1.0k
Christiane Rüster Germany 13 495 1.2× 313 1.2× 244 1.0× 320 1.5× 280 2.3× 21 1.3k
William A. Wilmer United States 15 559 1.4× 365 1.4× 181 0.7× 145 0.7× 60 0.5× 20 1.2k
Yung‐Hsiung Lai Taiwan 19 401 1.0× 272 1.0× 109 0.5× 179 0.9× 255 2.1× 43 1.2k
Berne Yee United States 10 455 1.1× 219 0.8× 84 0.3× 169 0.8× 112 0.9× 11 820
Leopoldo Ardiles Chile 15 554 1.4× 396 1.5× 214 0.9× 197 0.9× 132 1.1× 56 1.4k
Ernesto Martín‐Núñez Spain 18 548 1.4× 310 1.2× 130 0.5× 224 1.1× 99 0.8× 51 1.2k
Bryan R. Conway United Kingdom 20 451 1.1× 422 1.6× 181 0.7× 138 0.7× 50 0.4× 41 1.2k
Jianwei Tian China 24 605 1.5× 506 1.9× 191 0.8× 106 0.5× 154 1.3× 66 1.5k
Leyi Gu China 15 602 1.5× 364 1.4× 109 0.5× 119 0.6× 154 1.3× 43 1.2k

Countries citing papers authored by C. Aros

Since Specialization
Citations

This map shows the geographic impact of C. Aros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Aros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Aros more than expected).

Fields of papers citing papers by C. Aros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Aros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Aros. The network helps show where C. Aros may publish in the future.

Co-authorship network of co-authors of C. Aros

This figure shows the co-authorship network connecting the top 25 collaborators of C. Aros. A scholar is included among the top collaborators of C. Aros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Aros. C. Aros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hill, Charlotte, C. Aros, Ana María Vega-Letter, et al.. (2025). Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade. Frontiers in Immunology. 16. 1600792–1600792. 1 indexed citations
2.
3.
Pisoni, Roberto, C. Aros, Piero Ruggenenti, & Giuseppe Remuzzi. (2012). Mechanisms of progression of chronic renal disease.. PubMed. 13(3). 250–6. 4 indexed citations
4.
Carvajal, Gisselle, Alejandra Droguett, M. Eugenia Burgos, et al.. (2008). Gremlin: A Novel Mediator of Epithelial Mesenchymal Transition and Fibrosis in Chronic Allograft Nephropathy. Transplantation Proceedings. 40(3). 734–739. 43 indexed citations
5.
Mezzano, Sergio, Alejandra Droguett, M. Eugenia Burgos, et al.. (2007). Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis. Nephrology Dialysis Transplantation. 22(7). 1882–1890. 46 indexed citations
6.
Flores, Claudio, Leopoldo Ardiles, C. Aros, et al.. (2005). Valsartan-Induced Hematocrit Changes in Renal Transplant Patients. Transplantation Proceedings. 37(3). 1586–1588. 3 indexed citations
7.
Aros, C., et al.. (2005). No Gender-Associated Differences of Cyclosporine Pharmacokinetics in Stable Renal Transplant Patients Treated With Diltiazem. Transplantation Proceedings. 37(8). 3364–3366. 15 indexed citations
8.
Aros, C., et al.. (2005). Enfermedad renal crónica: clasificación, mecanismos de progresión y estrategias de renoprotección. Revista médica de Chile. 133(3). 338–48. 17 indexed citations
9.
Aros, C., et al.. (2005). Correlation Between C2 and AUC0–4 in Renal Transplant Patients Treated With Diltiazem. Transplantation Proceedings. 37(3). 1580–1582. 6 indexed citations
10.
Mezzano, Sergio, C. Aros, Alejandra Droguett, et al.. (2004). NF- B activation and overexpression of regulated genes in human diabetic nephropathy. Nephrology Dialysis Transplantation. 19(10). 2505–2512. 330 indexed citations
11.
Campbell, Ruth, Fabio Sangalli, Elena Perticucci, et al.. (2003). Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney International. 63(3). 1094–1103. 143 indexed citations
12.
Mezzano, Sergio, Alejandra Droguett, M. Eugenia Burgos, et al.. (2003). Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney International. 64(86). S64–S70. 152 indexed citations
13.
Mezzano, Sergio, C. Aros, Alejandra Droguett, et al.. (2003). Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy. Kidney International. 64(86). S39–S45. 48 indexed citations
14.
Ruggenenti, Piero, Claudio Flores, C. Aros, et al.. (2003). Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy. Diabetes Care. 26(2). 502–509. 19 indexed citations
15.
Aros, C., et al.. (2002). Tendinitis aquiliana asociada al uso de levofloxacino: comunicación de cuatro casos. Revista médica de Chile. 130(11). 1277–81. 6 indexed citations
16.
Ruggenenti, Piero, C. Aros, & Giuseppe Remuzzi. (2001). Renin-Angiotensin System, Proteinuria, and Tubulointerstitial Damage. Contributions to nephrology. 187–199. 5 indexed citations
17.
Ruggenenti, Piero, C. Aros, & Giuseppe Remuzzi. (2001). Thrombotic Microangiopathies in the Intensive Care Unit: Many Questions, Some Answers. Contributions to nephrology. 53–67. 2 indexed citations
18.
Mezzano, Sergio, Alejandra Droguett, M. Eugenia Burgos, et al.. (2000). Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney International. 57(1). 147–158. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Flores Breakdown of academic impact, for papers by Christiane Rüster Breakdown of academic impact, for papers by William A. Wilmer Breakdown of academic impact, for papers by Yung‐Hsiung Lai Breakdown of academic impact, for papers by Berne Yee Breakdown of academic impact, for papers by Leopoldo Ardiles Breakdown of academic impact, for papers by Ernesto Martín‐Núñez Breakdown of academic impact, for papers by Bryan R. Conway Breakdown of academic impact, for papers by Jianwei Tian Breakdown of academic impact, for papers by Leyi Gu
Rankless by CCL
2026